Amended in Assembly April 6, 2016

California Legislature—2015–16 Regular Session

Assembly BillNo. 2436


Introduced by Assembly Member Roger Hernández

February 19, 2016


An act to add Section 1367.207 to the Health and Safety Code,begin delete immediately following Section 1367.205,end delete and to add Section 10123.202 to the Insurance Code, relating to health care coverage.

LEGISLATIVE COUNSEL’S DIGEST

AB 2436, as amended, Roger Hernández. Health care coverage: disclosures: drug pricing.

Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law also provides for the regulation of health insurers by the Department of Insurance. Existing law imposes various requirements on contracts and policies that cover prescription drug benefits.

This bill would require a health care service plan contract or a policy of health insurance that is issued, amended, or renewed on or after January 1, 2017, and that provides coverage for prescription drug benefits to notify the enrollee orbegin delete insuredend deletebegin insert insured, at the time that a prescription drug is delivered or within 30 days of purchase,end insert of specified information related to the cost ofbegin delete aend deletebegin insert theend insert prescriptionbegin delete drug at the time that the drug is purchased or delivered.end deletebegin insert drug. The bill would require a health care service plan or a health insurer, in contracting with a pharmaceutical manufacturer for the purchase of a prescription drug, to require the manufacturer to disclose to the plan or insurer the cost of the prescription drug in United States dollars in Canada, Germany, and Mexico. The bill would make related legislative findings and declarations.end insert Because a willful violation of the bill’s requirements by a health care service plan would be a crime, the bill would impose a state-mandated local program.

The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.

This bill would provide that no reimbursement is required by this act for a specified reason.

Vote: majority. Appropriation: no. Fiscal committee: yes. State-mandated local program: yes.

The people of the State of California do enact as follows:

P2    1begin insert

begin insertSECTION 1.end insert  

end insert
begin insert

(a) The Legislature finds and declares that the
2escalating cost of prescription drugs is a major concern for
3Californians.

end insert
begin insert

4
(b) It is the intent of the Legislature in enacting this bill to
5provide consumers with information about the cost of prescription
6drugs, including the cost to the health plan or insurer and the cost
7in other countries.

end insert
begin insert

8
(c) It is not the intent of the Legislature in enacting this bill to
9encourage Californians to purchase or otherwise obtain
10prescription drugs from other countries in violation of federal law.

end insert
11

begin deleteSECTION 1.end delete
12
begin insertSEC. 2.end insert  

Section 1367.207 is added to the Health and Safety
13Code
, immediately following Section 1367.205begin insert, end insert to read:

14

1367.207.  

begin insert(a)end insertbegin insertend insert A health care service plan contract issued,
15amended, or renewed on or after January 1, 2017, that provides
16coverage for prescription drug benefits shall require the plan to
17notify the enrollee of the following at thebegin delete time of purchase orend delete time
18of deliverybegin insert or within 30 days of purchaseend insert of a prescription drug:

begin delete

8 19(a)

end delete

20begin insert(1)end insert The enrollee’s share of the cost for the prescription drug,
21including any copayment, coinsurance, or other cost sharing, and
22the accumulation of that cost sharing to the enrollee’s deductible,
23if any, or out-of-pocket maximum.

begin delete

12 24(b)

end delete

P3    1begin insert(2)end insert The cost of the prescription drug to the plan, after applying
2any discounts, rebates, or other reductions in cost to the plan.

begin delete

14 3(c)

end delete

4begin insert(3)end insert The cost of the prescription drug in United States dollars in
5the following countries:

begin delete

16 6(1)

end delete

7begin insert(A)end insert Canada.

begin delete

17 8(2)

end delete

9begin insert(B)end insert Germany.

begin delete

18 10(3)

end delete

11begin insert(C)end insert Mexico.

begin insert

12
(b) In contracting with a pharmaceutical manufacturer for the
13purchase of a prescription drug, a health care service plan or its
14contracting pharmacy benefits manager, if any, shall require the
15pharmaceutical manufacturer to disclose to the plan the cost of
16the prescription drug in United States dollars in Canada, Germany,
17and Mexico. If the pharmaceutical manufacturer fails to provide
18that information, the health care service plan may take that failure
19into account in determining whether to include the prescription
20drug in the plan’s drug formulary or in which tier of the plan’s
21drug formulary to place the prescription drug.

end insert
22

begin deleteSEC. 2.end delete
23
begin insertSEC. 3.end insert  

Section 10123.202 is added to the Insurance Code, 24immediately following Section 10123.201, to read:

25

10123.202.  

begin insert(a)end insertbegin insertend insert A policy of health insurance issued, amended,
26or renewed on or after January 1, 2017, that provides coverage for
27prescription drug benefits shall require the insurer to notify the
28insured of the following at thebegin delete time of purchase orend delete time of delivery
29begin insert or within 30 days of purchaseend insert of a prescription drug:

begin delete

26 30(a)

end delete

31begin insert(1)end insert The insured’s share of the cost for the prescription drug,
32including any copayment, coinsurance, or other cost sharing, and
33the accumulation of that cost sharing to the insured’s deductible,
34if any, or out-of-pocket maximum.

begin delete

30 35(b)

end delete

36begin insert(2)end insert The cost of the prescription drug to the insurer, after applying
37any discounts, rebates, or other reductions in cost to the insurer.

begin delete

32 38(c)

end delete

39begin insert(3)end insert The cost of the prescription drug in United States dollars in
40the following countries:

begin delete

P3   1 P3    1(1)

end delete

2begin insert(A)end insert Canada.

begin delete

2 3(2)

end delete

4begin insert(B)end insert Germany.

begin delete

3 5(3)

end delete

6begin insert(C)end insert Mexico.

begin insert

7
(b) In contracting with a pharmaceutical manufacturer for the
8purchase of a prescription drug, a health insurer or its contracting
9pharmacy benefits manager, if any, shall require the
10pharmaceutical manufacturer to disclose to the insurer the cost
11 of the prescription drug in United States dollars in Canada,
12Germany, and Mexico. If the pharmaceutical manufacturer fails
13to provide that information, the health insurer may take that failure
14into account in determining whether to include the prescription
15drug in the insurer’s drug formulary or in which tier of the
16insurer’s drug formulary to place the prescription drug.

end insert
17

begin deleteSEC. 3.end delete
18
begin insertSEC. 4.end insert  

No reimbursement is required by this act pursuant to
19Section 6 of Article XIII B of the California Constitution because
20the only costs that may be incurred by a local agency or school
21district will be incurred because this act creates a new crime or
22infraction, eliminates a crime or infraction, or changes the penalty
23for a crime or infraction, within the meaning of Section 17556 of
24the Government Code, or changes the definition of a crime within
25the meaning of Section 6 of Article XIII B of the California
26Constitution.



O

    98